Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy for gynaecological malignancies.

George Coukos1, Jose R Conejo-Garcia, Richard B S Roden

  • 1Abramson Cancer Research Institute, Center for Research on Reproduction and Women's Health, University of Pennsylvania, Philadelphia, PA 19104, USA.

Expert Opinion on Biological Therapy
|August 27, 2005
PubMed
Summary

Novel immunotherapies show promise for preventing and treating cervical and ovarian cancers. Targeting human papillomavirus (HPV) in cervical cancer and exploiting the immunogenicity of ovarian cancer are key strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024.

Frontiers in immunology·2026
Same author

Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing.

Molecular therapy. Oncology·2025
Same author

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Journal for immunotherapy of cancer·2025
Same author

Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan.

Cell reports methods·2025
Same author

Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps.

Trends in cancer·2025

Area of Science:

  • Gynecologic Oncology
  • Immunology
  • Cancer Therapeutics

Background:

  • Gynaecological malignancies (excluding breast cancer) result in ~25,000 US deaths annually, necessitating innovative treatments.
  • Cervical cancer shows promise for immunotherapy due to human papillomavirus (HPV) xenoantigens recognized by the immune system.
  • Emerging evidence suggests ovarian cancer is also immunogenic, making it a viable target for immunotherapy.

Purpose of the Study:

  • To review the principles and challenges of immunotherapy for cervical and ovarian cancers.
  • To provide an expert assessment of current and future directions in gynecologic cancer immunotherapy.

Main Methods:

  • Literature review focusing on immunotherapy principles and applications.
  • Analysis of preclinical and clinical data for HPV-targeted therapies in cervical cancer.

Related Experiment Videos

  • Evaluation of immunogenicity and immunotherapy approaches for ovarian cancer.

    • Main Results:

    • Targeting HPV xenoantigens has demonstrated significant promise in preclinical and clinical settings for cervical cancer.
    • Ovarian cancer's immunogenicity supports its potential for successful immunotherapy interventions.
    • The review synthesizes current knowledge and highlights areas for future research.

    Conclusions:

    • Immunotherapy represents a promising avenue for managing cervical and ovarian cancers.
    • Further research and clinical studies are essential to optimize immunotherapeutic strategies for these malignancies.
    • Addressing the challenges in gynecologic cancer immunotherapy is crucial for improving patient outcomes.